Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818529 · ClinicalTrials.gov registry record
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Completed
- Registry status
- 237
- Enrollment target
NCT03818529 is a clinical trial that has completed, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 237 participants.
The verdict
NCT03818529 has completed, sponsored by American Thrombosis and Hemostasis Network.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
Study Summary
This is a multi-center cohort study of approximately 250 previously untreated patients (PUPs) with congenital moderate to severe hemophilia A or B in a network of up to 50 US Hemophilia Treatment Centers (HTCs). Participants will be followed as they receive their first 50 exposure days (ED) to clotting factor replacement product, both prospectively and retrospectively. The data collected on evolving treatment practices will define the incidence and risk factors for inhibitor development during the high risk period of first 50 ED and improve the outcomes of this vulnerable population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818529
The ClinicalTrials.gov registry entry for NCT03818529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Thrombosis and Hemostasis Network, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03818529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818529 about?
NCT03818529 is a clinical study titled "ATHN 8: Previously Untreated Patients (PUPs) Matter Study". This is a multi-center cohort study of approximately 250 previously untreated patients (PUPs) with congenital moderate to severe hemophilia A or B in a network of up to 50 US Hemophilia Treatment Centers (HTCs). Participants will be followed as they receive their first 50 exposure days (ED) to clott...
What is the current status of trial NCT03818529?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2018-10-03. Estimated completion is 2022-12-31.
Who is sponsoring clinical trial NCT03818529?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.